EFDID: 427911EFD: View Filing

Issuer: ACELRX PHARMACEUTICALS INC (0001427925) - D

Accession: 0001437749-22-001502 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0001427925
  • Entity Name:
    ACELRX PHARMACEUTICALS INC
  • Entity Type:
    Corporation
  • Jurisdiction:
    DELAWARE
  • Year of Inc:
    Over 5 years ago
  • Address:
    25821 Industrial Boulevard, Suite 400
    Hayward, CA 94545
  • Persons:
    Related Persons 12
    Vincent Angotti
    Executive Officer, Director
    Richard Afable
    Director
    Marina Bozilenko
    Director
    Mark Edwards
    Director
    Stephen Hoffman
    Director
    Raffi Asadorian
    Executive Officer
    Pamela Palmer
    Executive Officer, Director
    Badri Dasu
    Executive Officer
    Adrian Adams
    Director
    Howard Rosen
    Director
    Mark Wan
    Director
    Jill Broadfoot
    Director
EDGAR: Offering Information
  • Accession Date:
    01/24/2022
  • First Sale Date:
    01/07/2022
  • Offering Amount:
    $5,960,979
  • Amount Sold:
    $5,160,997
  • Amount Remaining:
    $799,982
  • Exemptions:
    Rule 506
  • Security Type(s):
    Equity
EFD: Current State Notices
View Notices

Notices found in EFD

Filed:CA, DC, MA, MI, NH, PA
Inactive:NY, VT
EDGAR: Sales Compensation Recipient Information

There were no Sales Compensation Recipient Information associated with this Accession Number.

EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
ACELRX PHARMACEUTICALS INC/s/ Raffi AsadorianRaffi AsadorianChief Financial Officer2022-01-24